Patents by Inventor Randy Lane Bell

Randy Lane Bell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense modulation of Notch (Drosophila) homolog 4 expression
    Publication number: 20040077568
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of Notch (Drosophila) homolog 4. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Notch (Drosophila) homolog 4. Methods of using these compounds for modulation of Notch (Drosophila) homolog 4 expression and for treatment of diseases associated with expression of Notch (Drosophila) homolog 4 are provided.
    Type: Application
    Filed: October 16, 2002
    Publication date: April 22, 2004
    Applicant: Isis Pharmaceuticals Inc.
    Inventors: Andrew T. Watt, Randy Lane Bell
  • Antisense modulation of CD36 expression
    Publication number: 20040077567
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of CD36. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding CD36. Methods of using these compounds for modulation of CD36 expression and for treatment of diseases associated with expression of CD36 are provided.
    Type: Application
    Filed: October 16, 2002
    Publication date: April 22, 2004
    Applicants: Isis Pharmaceuticals Inc., Abbott Laboratories
    Inventors: Andrew T. Watt, Randy Lane Bell